HIV/AIDS

Libya: Aid for a besieged town Ivory Coast: The fear remains Haiti: The new hospital HIV / AIDS: A roadmap for the next decade
Governments must commit to massively scale up treatment at UN Summit on AIDS Governments will meet at the United Nations in New York for an HIV/AIDS Summit from 8 to 10 June, to discuss the global response to the epidemic over the next five to ten years. Hanging in the balance will be the lives of...
The prototype of a new tool for rapidly measuring the viral load of HIV, named SAMBA (Simple AMplification Based Assay), is currently being evaluated at our AIDS programme in Chiradzulu in Malawi. If the results of this trial are positive, the implementation of this test will represent a net...
Pharmaceutical giant’s refusal to participate in patent pool undermines access to key AIDS drugs > Click here to Tell Johnson & Johnson to join the patent pool Pharmaceutical giant Johnson & Johnson is putting the lives of people living with HIV at stake by refusing to participate in the...
Tuberculosis: progress in screening, South Sudan: A nation facing major challenges, Fistula: The backyard disease, Mali: vaccinating against meningitis epidemics, HIV/AIDS -- marching for generics
Democratic Republic of the Congo -- A million children immunized, Chechnya -- overcoming operational challenges, Malawi -- 10 years of antiretrovirals, Lebanon -- Healing invisible wounds
In July 2002, Fred MINANDI, one of MSF's first patients in Malawi to receive antiretroviral drugs (ARVs), spoke about his daily life at the 14th international conference on HIV/AIDS, held in Barcelona. At that time, donors refused to fund HIV/AIDS programs as they did not believe that African...
Martha HUCKABEE was head of mission in Malawi from June 2009 to December 2010. While patient treatment in Malawi has changed significantly over 10 years, the new World Health Organization (WHO) directives create new challenges – particularly financial ones. How will the new WHO recommendations...
Licenses just agreed between three generic manufacturers and pharmaceutical company Tibotec, owned by Johnson & Johnson, will keep a promising new AIDS medicine out of the hands of many patients across the developing world, the international medical humanitarian organisation Médecins Sans...
In 2010, international donors shifted their focus away from AIDS, threatening the advances that have been made in treating the disease over the last decade. New scientific evidence and treatment recommendations reinforce the need to provide people with better treatment and earlier during the...
Subscribe to RSS - HIV/AIDS